Investors / United States / W Fund
W Fund
Venture capital · Seattle, WA, United States · North America
The W Fund is an early-stage venture fund that invests in start-ups spinning out of the University of Washington and other research institutions across Washington state. It aims to invest approximately $20 million over four years and makes initial investments of up to $500K, typically alongside other venture and angel groups.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordslife sciencessoftwareitengineeringclean techuniversity spinouts
Your fit with W Fund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsW Fund lists 12 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (64%), AI & Machine Learning (18%) and Robotics & Hardware (9%). 100% of its companies are based in United States. It invests most often alongside SeaChange, SpringRock Ventures and Agent Capital.
No funding round on record names W Fund yet, so the figures come from its portfolio page.
Round figures show recent activity, not W Fund's whole history. Rounds on record name 0 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 90th | 64% in its largest sector |
| Reach | 19th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1083%
- No longer answers00%
- Points to another company217%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 64% | 15% |
| AI & Machine Learning | 18% | 18% |
| Robotics & Hardware | 9% | 1% |
| Industrial & Manufacturing | 9% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare W Fund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| The company develops new therapies, including small molecule therapies, to address devastating diseases with limited treatment options. | Healthcare & Biotech | Portfolio page | ||
| BEAT BioTherapeutics Corp. is developing a novel gene therapy for the treatment of heart failure. | Healthcare & Biotech | Portfolio page | ||
| Cardiac Insight, Inc is a medical device company that provides cardiac diagnostic products, including handheld and wearable ECG devices with software-assisted analysis. | Healthcare & Biotech | Portfolio page | ||
| C-SATS provides a platform for surgeons to improve their proficiency through performance analytics, self-learning opportunities, and peer-to-peer interactions | Healthcare & Biotech | Portfolio page | ||
| Cyrus Biotechnology is a computationally-driven discovery company focused on developing therapeutics from naturally existing proteins using computational modeling and deep mutagenesis. | Healthcare & Biotech | Portfolio page | ||
AI & Machine LearningAI & Machine Learning | Portfolio page | |||
| Nexgenia develops smart magnetic nanoparticles for molecular and cell separations for diagnostic and life science applications. | Healthcare & Biotech | Portfolio page | ||
| Olis Robotics provides a platform to analyze and troubleshoot automation systems in factories using AI and edge computing | Industrial & Manufacturing | Portfolio page | ||
| The company develops and provides a platelet strength test for assessing primary hemostasis | Healthcare & Biotech | Portfolio page | ||
| TwinStrand Biosciences develops and provides next-generation sequencing technology for detecting rare variants and measuring residual disease | Healthcare & Biotech | Portfolio page | ||
| WiBotic systems work with any battery on any robot using reliable charging hardware and fleet energy management software to maximize robot productivity. | Robotics & Hardware | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- thewfund.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get W Fund's profile as data
Pull W Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/thewfund.com
# also
GET /v1/firms/thewfund.com/portfolio
GET /v1/firms/thewfund.com/coinvestors
GET /v1/firms/thewfund.com/news